Kinins

Kinins are small chains of amino acids called peptides. They act as chemical messengers in the body. The best-known kinin is bradykinin. Another is kallidin.

Kinins help control blood vessel width, fluid movement from blood vessels into tissues, pain signals, and parts of the inflammatory response. Inflammation is the body’s response to injury, infection, or irritation.

Kinins are not a disease or diagnosis. They are part of several normal body systems. They are made when needed and broken down quickly, often within seconds or minutes.

Most people will never have a kinin test. The subject usually comes up when discussing:

• Swelling called angioedema
• A dry cough or swelling linked to an ACE inhibitor like lisinopril or ramipril
• Hereditary or acquired problems involving C1 inhibitor
• Research into inflammation, blood pressure, and pain

The word kinin is not related to quinine, the medicine historically used for malaria. It is also different from a cytokine, which is another broad type of immune-system messenger.

Kinins are released from larger proteins called kininogens. Enzymes called kallikreins cut these proteins to release active kinins.

There are two closely connected routes. Plasma kallikrein, which circulates in the blood, can release bradykinin from high-molecular-weight kininogen. Tissue kallikrein can produce kallidin from another form of kininogen. These reactions are controlled by several proteins so that activity stays limited.

Bradykinin and kallidin send signals through bradykinin receptors on cells. The main receptors are:

• B2 receptors, which are normally present in many tissues
• B1 receptors, which become more active during inflammation or tissue injury

When these receptors are activated, blood vessels can widen. Their walls may also allow more fluid to move into nearby tissue. Kinins can stimulate pain-sensitive nerves and affect smooth muscle in organs such as the gut.

These effects can be useful. Increased blood flow and sensitivity around an injury may support the body’s local response. Problems can arise when kinin production is poorly controlled or breakdown is reduced.

Several enzymes break kinins down. One is angiotensin-converting enzyme, usually shortened to ACE. ACE also has a separate role in the hormone system that controls blood pressure.

ACE inhibitor medicines reduce ACE activity. Their main purpose is to affect blood pressure and heart or kidney function, but they also slow bradykinin breakdown. This helps explain why some people develop a persistent dry cough or, less commonly, angioedema while taking an ACE inhibitor.

Understanding kinins can help explain why swelling does not always come from an allergy.

Many allergic reactions are driven mainly by histamine, another chemical messenger. Histamine-related swelling often occurs with itching or raised, itchy welts called hives. Antihistamines like cetirizine or loratadine target this pathway.

Bradykinin-mediated angioedema usually does not cause hives or itching. It may affect the face, lips, tongue, throat, limbs, genitals, or bowel wall. Swelling of the bowel wall can cause severe abdominal pain, nausea, or vomiting.

This distinction matters because medicines used for ordinary allergic swelling may not control bradykinin-mediated swelling. However, it can be difficult to identify the cause during an emergency. Clinicians still treat suspected anaphylaxis promptly while assessing other possibilities.

Kinins also matter when reviewing medicine effects. A dry cough associated with an ACE inhibitor is not the same as angioedema. The cough is usually not dangerous, but it can be persistent. Angioedema involving the mouth, tongue, or throat can threaten the airway and needs emergency assessment.

Kinin measurements are rarely part of routine care. Bradykinin is short-lived and difficult to measure reliably because blood collection and handling can change the result. Clinicians usually investigate the pathway with other blood tests and the person’s medical history.

Several named conditions or situations involve excess bradykinin activity.

ACE inhibitor-associated angioedema occurs when swelling develops in someone taking an ACE inhibitor. It can begin soon after starting the medicine or after a long period of treatment. Not every episode of swelling in someone taking an ACE inhibitor has that cause, so clinical assessment remains important.

Hereditary angioedema due to C1 inhibitor deficiency or dysfunction is a genetic condition. C1 inhibitor is a regulatory protein that helps restrain plasma kallikrein and other blood pathways. When too little functional C1 inhibitor is available, excess bradykinin may be produced. Other, less common forms of hereditary angioedema can occur with normal C1 inhibitor test results.

Acquired angioedema due to C1 inhibitor deficiency is not inherited. It may be associated with another medical condition or with antibodies that interfere with C1 inhibitor.

The kallikrein-kinin system can also become active during tissue injury, inflammation, and some severe illnesses. Its exact role is complex because it interacts with clotting, complement, and blood-pressure systems. Complement is a group of blood proteins involved in immune defence and inflammation.

These are conditions and biological situations related to kinins. Kinins themselves are not an illness.

Seek emergency help for sudden swelling of the tongue, mouth, or throat; trouble breathing or swallowing; a new hoarse or muffled voice; collapse; or rapidly worsening swelling. Do not wait for a routine appointment.

Severe or persistent abdominal pain, repeated vomiting, or signs of dehydration also need prompt medical assessment. Many conditions can cause these problems, so they should not automatically be attributed to bradykinin.

There is nothing you need to monitor or test simply because kinins exist. Routine bradykinin screening is not recommended for people without a relevant medical concern.

If you take an ACE inhibitor, keep an up-to-date list of your medicines. ACE inhibitor names often end in “-pril,” but use the exact name from your prescription label rather than relying on the ending alone.

Arrange routine follow-up if you develop a persistent dry cough after starting an ACE inhibitor. Ask whether the medicine could be contributing and whether an alternative is appropriate. Do not change a prescribed cardiovascular medicine on your own.

If you have repeated swelling, especially without hives, record:

• The body areas affected and how long swelling lasts
• Any abdominal pain, vomiting, itching, or hives
• Medicines taken before the episode
• Dental work, illness, injury, hormonal changes, or other possible triggers
• Whether close relatives have had similar episodes

Photographs can help document visible swelling, but they do not replace medical assessment.

Ask a clinician whether testing for bradykinin-mediated angioedema is appropriate. Available blood tests include complement component C4 and the amount and function of C1 inhibitor. C1q testing may help in selected cases. Genetic testing is sometimes used when hereditary angioedema remains a concern.

A primary care clinician can begin the assessment. An allergy and immunology specialist may be helpful for recurrent unexplained swelling or abnormal complement and C1 inhibitor results.

Are kinins harmful?

Not by themselves. Kinins have normal roles in blood flow, inflammation, and pain signalling. Harm can occur when their production or breakdown is not well controlled.

Can a routine blood test show my bradykinin level?

Usually not in a clinically useful way. Bradykinin breaks down quickly and is sensitive to how a sample is collected. Related conditions are generally assessed with history, medicine review, complement tests, and C1 inhibitor tests.

Does swelling without hives always mean bradykinin is responsible?

No. The absence of hives can raise suspicion, but it does not prove the cause. Infection, local inflammation, medication reactions, and other conditions can also cause swelling.

Why may antihistamines not help bradykinin-mediated swelling?

Antihistamines block histamine signals. They do not directly block bradykinin production or its receptors. In an unclear emergency, clinicians may still treat possible anaphylaxis while protecting the airway and investigating other causes.

Is an ACE inhibitor cough an allergy?

Usually not. It is generally considered a medicine effect related partly to reduced breakdown of bradykinin and similar peptides. It should still be discussed with the prescribing clinician.

Can kinins be removed through diet?

No specific diet removes kinins or switches off the kinin system. Kinins are made and broken down inside the body. Food labels do not normally list them.